Cargando…
Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?
Current therapies for treating Glioblastoma (GB), and brain tumours in general, are inefficient and represent numerous challenges. In addition to surgical resection, chemotherapy and radiotherapy are presently used as standards of care. However, treated patients still face a dismal prognosis with a...
Autores principales: | Alfonso-Triguero, Paula, Lorenzo, Julia, Candiota, Ana Paula, Arús, Carles, Ruiz-Molina, Daniel, Novio, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223043/ https://www.ncbi.nlm.nih.gov/pubmed/37242036 http://dx.doi.org/10.3390/nano13101619 |
Ejemplares similares
-
Advances in Preclinical/Clinical Glioblastoma Treatment: Can Nanoparticles Be of Help?
por: Ruiz-Molina, Daniel, et al.
Publicado: (2022) -
Establishing Imaging Biomarkers of Host Immune System Efficacy during Glioblastoma Therapy Response: Challenges, Obstacles and Future Perspectives
por: Candiota, Ana Paula, et al.
Publicado: (2022) -
Synthesis and Validation of a Bioinspired Catechol-Functionalized Pt(IV) Prodrug for Preclinical Intranasal Glioblastoma Treatment
por: Mao, Xiaoman, et al.
Publicado: (2022) -
Intranasal Administration of Catechol-Based Pt(IV) Coordination Polymer Nanoparticles for Glioblastoma Therapy
por: Mao, Xiaoman, et al.
Publicado: (2022) -
Immune System-Related Changes in Preclinical GL261 Glioblastoma under TMZ Treatment: Explaining MRSI-Based Nosological Imaging Findings with RT-PCR Analyses
por: Calero-Pérez, Pilar, et al.
Publicado: (2021)